In situ detection of warfarin using time-correlated single-photon counting

Biochemical and Biophysical Research Communications

Volumn 407, Issue 1, 2011, Pages 60-62

  Rosengren, Annika M ^a   Karlsson, Björn C G ^a   Näslund, Inga ^b   Andersson, Per Ola ^b   Nicholls, Ian A ^a,c  

^a LINNAEUS UNIVERSITY   (Sweden)

^b SWEDISH DEFENCE RESEARCH AGENCY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Human serum albumin; MIP; Molecularly imprinted polymer; Sudlow I; Time correlated single photon counting; Time resolved fluorescence spectroscopy; Warfarin

Indexed keywords

HUMAN SERUM ALBUMIN; MOLECULARLY IMPRINTED POLYMER; POLYMER; UNCLASSIFIED DRUG; WARFARIN;

ARTICLE; DRUG BINDING SITE; DRUG DETERMINATION; FLUORESCENCE SPECTROSCOPY; PRIORITY JOURNAL; SPECTROSCOPY; TIME CORRELATED SINGLE PHOTON COUNTING SPECTROSCOPY;

ANTICOAGULANTS; ISOMERISM; MOLECULAR IMPRINTING; PHOTONS; SPECTRUM ANALYSIS; TIME FACTORS; WARFARIN;

EID: 79953162370     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.02.103     Document Type: Article

References (14)

1. Landefeld C.S., Beyth R.J. Anticoagulant-related bleeding - clinical epidemiology, prediction, and prevention. Am. J. Med. 1993, 95:315-328.
2. Ansell J., Hirsh J., Poller L., Bussey H., Jacobson A., Hylek E. The pharmacology and management of the vitamin K antagonists. Chest 2004, 126:204S-233S.
3. Karlsson B.C.G., Rosengren A.M., Andersson P.O., Nicholls I.A. The spectrophysics of warfarin: implications for protein binding. J. Phys. Chem. B. 2007, 111:10520-10528.
4. Karlsson B.C.G., Rosengren A.M., Andersson P.O., Nicholls I.A. Molecular insights on the two fluorescence lifetimes displayed by warfarin from fluorescence anisotropy and molecular dynamics studies. J. Phys. Chem. B. 2009, 113:7945-7949.
5. Henschel H., Karlsson B.C.G., Rosengren A.M., Nicholls I.A. The mechanistic basis for warfarin's structural diversity and implications for its bioavailability. J. Mol. Struct.-Theochem. 2010, 958:7-9.
6. Karlsson B.C.G., Rosengren A.M., Näslund I., Andersson P.O., Nicholls I.A. Synthetic human albumin Sudlow I binding site mimics. J. Med. Chem. 2010, 53:7932-7937.
7. Nicholls I.A., Karlsson B.C.G., Rosengren A.M., Henschel H. Warfarin: an environment-dependent switchable molecular probe. J. Mol. Recognit. 2010, 23:604-608.
8. Godfrey E., Woessner W.W., Benotti M.J. Pharmaceuticals in on-site sewage effluent and ground water. Western Montana, Ground Water. 2007, 45:263-271.
9. Molecularly Imprinted Polymers: Man-made Mimics of Antibodies and Their Applications in Analytical Chemistry 2001, Elsevier, Amsterdam. B. Sellergren (Ed.).
10. Alexander C., Andersson H.S., Andersson L.I., Ansell R.J., Kirsch N., Nicholls I.A., et al. Molecular imprinting science and technology: a survey of the literature for the years up to and including 2003. J. Mol. Recognit. 2006, 19:106-180.
11. Unge P., Svedberg L.E., Nordgren A., Blom H., Andersson T., Lagerström P.O., et al. A study of the interaction of omeprazole and warfarin in anticoagulated patients. Br. J. Clin. Pharmacol. 1992, 34:509-512.
12. Lombardi R., Chantarangkul V., Cattaneo M., Tripodi A. Measurement of warfarin in plasma by high performance liquid chromatography (HPLC) and its correlation with the international normalized ratio. Thromb. Res. 2003, 111:281-284.
13. He M., Korzekwa K.R., Jones J.P., Rettie A.E., Trager W.F. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch. Biochem. Biophys. 1999, 372:16-28.
14. Valente E.J., Lingafelter E.C., Porter W.R., Trager W.F. Structure of warfarin in solution. J. Med. Chem. 1977, 20:1489-1493.